| Dr Abdool Karim is an infectious diseases epidemiologist whose main current research
interests are in understanding the evolving HIV epidemic in South Africa; factors influencing acquisition of HIV
infection in adolescent girls; and sustainable strategies to introduce HAART in resource-constrained settings.
She is an Adjunct Associate Professor in Epidemiology at the Mailman School of Public Health at Columbia University.
In addition she co-ordinates the Columbia-University Southern African Fogarty AIDS International Training and Research
Programme in Durban, South Africa. She is also an Adjunct Associate Professor in Public Health and Family Medicine at
the Nelson R Mandela School of Medicine, University of Natal, South Africa. She is an Executive Committee member of
CAPRISA (Centre for the AIDS Program of Research in South Africa) - a large multi-institutional AIDS Research Centre
and of the HPTN (HIV Prevention Trials Network) Leadership Group - a NIH funded network for HIV prevention science
with US and international sites. She chairs the HPTN Ethics Working Group.
|
|
In addition she is an Executive Director of the International Partnership for Microbicides,
a newly established not for profit organization to fast-track microbicide development. She serves as a temporary
consultant to WHO, UNAIDS and UNDP on several HIV/AIDS related expert committees in relation to gender, ethics,
vaccines, treatment and research capacity building. As Scientific Director of the South African Medical Research
Council HIVNET site she garnered extensive experience in the conduct of HIV prevention trials. She also has
extensive policy and programmatic experience that stems from her term as the first National Director of the
South African National HIV/AIDS and STD Programme that was established shortly after the first democratic
elections. Dr Abdool Karim is an Editorial Board member of HIV Clinical Trials and serves as a reviewer for
several infectious diseases and social science journals. She has published widely in the field of HIV/AIDS.
She has been a member of several international AIDS conference scientific committees and has delivered keynote
addresses at several international AIDS conferences.
|
